Diagnostics; making a difference

Member Press Releases

Current Articles | Categories | Search | Syndication

13 May 2016  
Rapid diagnostic test and shorter, cheaper treatment signal new hope for multidrug-resistant tuberculosis patients
By @ 16:39 :: 92 Views



New WHO recommendations aim to speed up detection and improve treatment outcomes for multidrug resistant tuberculosis (MDR-TB) through use of a novel rapid diagnostic test by Hain Lifescience and a shorter, cheaper treatment regimen.

Read More

29 April 2016  
Abingdon Health Ltd announces collaboration with Sumitomo Chemical Co., Ltd
By @ 14:15 :: 103 Views

18 April 2016
Abingdon Health Ltd (“Abingdon Health”) today announces the signing of a collaboration agreement
with Sumitomo Chemical Co., Ltd (“Sumitomo Chemical”) to develop a next generation multiplexed
point of care biosensor device.
Read More

28 April 2016  
Facilitating cardiology decision-making at the point-of-care
By @ 14:28 :: 97 Views

 

As the prevalence of cardiovascular disease (CVD) continues to grow, Rhys Tassell, Point of Care Testing Team Lead at Cambridge University Hospitals NHS Foundation Trust explains how Addenbrooke’s Hospital’s Emergency Department is ensuring a swift diagnosis at the point-of-care. 

Read More

22 April 2016  
Binding Site receives a Queen’s Award for Enterprise
By @ 16:21 :: 92 Views

Binding Site is delighted and humbled to announce that it has been awarded a Queen’s award for enterprise - the UK’s highest accolade for business success. The honour has been awarded in the category of ‘International Trade’.

Read More

21 April 2016  
Safe, Compliant Mailing for Larger Sample Volumes
By @ 10:49 :: 103 Views



Do you need to mail samples of fluids in volumes up to 120ml?

 

SpeciSafe® secondary packaging containers provide a safe, convenient and economical solution for compliant mailing of biohazardous and clinical specimens. The extensive SpeciSafe range includes solutions for screw cap microtubes, serum vials, vacuum blood collection tubes, cryovials, Bijou containers, swabs/transport tubes, universal containers and is now extended to include a pack to seal SampleTite or similar 40ml, 60ml or 90ml containers.

 

Read More

20 April 2016  
New BÜHLMANN fCAL® turbo Turbidimetric Faecal Calprotectin Assay
By @ 12:12 :: 97 Views



Faecal calprotectin (fCAL) has become an increasingly important biomarker for in vitro diagnostic detection of gut inflammation. It enables clinicians to make initial diagnostic predictions without the need for invasive and costly endoscopies. With the advent of NICE diagnostics guidance [DG11], the demand for faecal calprotectin testing has risen significantly. 


Read More

20 April 2016  
Beckman Coulter Diagnostics DxN VERIS Molecular Diagnostics System* has the Potential to Positively Impact Clinical Service Delivery
By @ 10:03 :: 110 Views




Findings from Sheffield Teaching Hospitals NHS Trust

 

Nyon, Switzerland — (20 April 2016) Beckman Coulter today announced that the Sheffield Teaching Hospitals Virology Department is the first site to introduce the company’s DxN VERIS HBV assay* routinely.  Operating on the DxN VERIS Molecular Diagnostics System, that consolidates DNA extraction, amplification and detection within a single automated instrument, the HBV assay will allow the laboratory to offer service users greater precision at low HBV viral loads as well as improved turnaround times. 

 

Read More

05 April 2016  
DEEP PROTEIN PROFILING KEY TO IMPROVING CANCER TREATMENT
By @ 13:10 :: 102 Views

For immediate release: 5th April 2016; Cobham, UK. As global experts in mapping and analysis of protein changes in systems-wide biology, Proteome Sciences plc  is strongly encouraged by two recent reports that emphasise the importance of protein profiling to improve outcomes in cancer treatment. These highlight the growing need for more detailed, personal assessment of protein profiles to improve the management of cancer treatment.

Read More

04 April 2016  
Viral load workflow improvements and time savings achieved using DxN VERIS Molecular Diagnostics System
By @ 15:29 :: 121 Views

 

Niguarda Hospital case study now available

 

Nyon, Switzerland — (30 March 2016) A case study describing the experiences of Niguarda Hospital, Milan, in assessing the new DxN VERIS Molecular Diagnostics System is now available from Beckman Coulter. The case study describes the workflow improvements and reduced turnaround times that the hospital’s Molecular Biology Laboratory was able to achieve for viral load measurements using the DxN VERIS system.

 

Read More

17 March 2016  Rachel Myers
Are IVD Medical Device companies ready for the challenge of meeting new EU regulatory legislation?
By Rachel Myers @ 16:44 :: 193 Views :: 2016



The introduction of new EU regulatory legislation is likely to have a major impact on In Vitro Diagnostic (IVD) manufacturers as they meet new external EU compliance requirements. Currently 80% of all IVD devices on the market in the EU meet self-certified compliance requirements but new EU legislation means they will have to meet rules based on classifications set by the Global Harmonization Task Force.

 

Read More

Previous Page | Next Page